Good day today and nice to close at 50c. I do feel we are approaching a buying climax soon and we will need to recoil before attempting ATH. Chart indicates it too imo. Could always be wrong TA should only be used as a guide. Personally haven't sold any yet but might take a few profits around 55c and look to re-enter lower if we don't push on from there. There is a nice big wall of shares there so will be pretty easy to know the demand for shares around that level and make a short term decision based on that. Long term though everything sounds great and will keep a big core parcel as I'm a huge believer in BDA.
The report read well but yeah damn our costs are still too high. It looked like sales for the quarter were down too compared to last? Unless I am reading something wrong. Anyone care to comment?
The launch into US sounds positive and imo is the likely reason for our big push from high 20's a few weeks ago. We already have established product line heading into the biggest market and don't have to pay our own marketing as we enter. Also only ASX company to have GRAS in this space so if anyone wants exposure then BDA is the place to be.
Hopefully new sales in US will compensate for the high costs we still have but the higher revenue/lower costs trajectory is on the right path and if you want big gains you gotta enter these companies just before they are cashflow positive.
Keep it up Jo and BDA mgmt
- Forums
- ASX - By Stock
- BOD
- Ann: Quarterly Activities Report and Appendix 4C
Ann: Quarterly Activities Report and Appendix 4C, page-10
Featured News
Add BOD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BOD (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online